Medicon Village Science Park

Överraskande studieresultat om testosteron – Minskade inte risk för frakturer

Det är känt att behandling med testosteron ökar bentäthet och benkvalitet. Men nu tyder en studie på att tillförsel av det manliga könshormonet ändå inte medför...

The Crucial Role of Core Imaging Facility Managers

User story from ZEISS and the University of York.

Ingrid Lönnstedt: What does the p-value mean?

The smaller the better, and preferably smaller than 0.05. A p-value smaller than 5% means that the treatment effect is statistically significant at 5% significa...

How to avoid measurement inaccuracies due to wear

Expert tip from ZEISS.

“I am driven by the desire to develop a product that can be sold worldwide”

Ranked number one in the world by the WHO in diarrhoea research and soon in phase III studies for its vaccine candidate – Scandinavian Biopharma is rushing forw...

Life Science Sweden heads to the Oresund region! ‒ Hello there Michael Linnell

Life Science Sweden’s The Future of Swedish Danish Life Science and New Updates in Drug Formulation & Bioavailability meetings are coming up soon. We asked Mich...

Lista: Här är biotechbolagen som startade i Sverige förra året

Tuffa ekonomiska tider och försiktiga investerare drabbar små biotechbolag. Trots detta finns det företagare som vågar satsa och starta nytt. Life Science Swede...

Festo AB

Caroline Leksell Cooke ny chef på Elekta

Elekta har rekryterat Caroline Leksell Cooke till ny Senior Vice President och Head of Neuro Solutions. Hon börjar sin nya tjänst den 1 november.

Extensive agreements signed at Scilifelab

Four agreements were signed between Swedish and Dutch life science players in connection with the Dutch state visit earlier this month.

Uppsala-based company wins important patent dispute – but the decision is subject to appeal

A US district court has ruled in favour of Orexo in a dispute over the patent protecting the Swedish company’s drug Zubsolv, developed for treating patients wit...

Galenica AB

Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.

“We aim to be a start-up company with an academic spirit”

Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working...

Recipharm ingår samarbete med global koncern

Recipharm ingår ett strategiskt samarbete med den globala franska koncernen Product Life Group (PLG).

Olika bud om distansarbete – ”Vi ber vår personal att komma tillbaka till kontoret”

Hur viktigt är det för life science-bolagen att erbjuda distansarbete? Den frågan väckte debatt och fick många olika svar vid en paneldiskussion om talangrekryt...

Alert from the Swedish Medicines Agency: Many complications with gastric balloons

According to the Swedish Medicines Agency, an increasing number of serious complications are being reported in procedures with gastric balloons as a method for ...

He takes over the chairmanship of Karolinska Development

Ben Toogood is appointed as the new chairman of Karolinska Developments.

New diagnostic rules raise concerns

In a panel discussion, several voices from academia and the industry expressed concerns about the transition to the new regulatory framework for in-vitro diagno...

Christina Lloyd: ”Vi måste koppla kvinnohälsa till ledarskap”

Nätverket Vilda, som verkar för att stärka kvinnligt ledarskap och främja jämställdhet inom life science, har på kort tid vuxit i medlemsantal. Nu är siktet ins...

FOKUS Patient turns international

FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.

He got inside the head of Sweden’s vaccine hunter

The hunt for the COVID-19 vaccine is the theme of the new book Vaccinjägaren (The Vaccine Hunter). It tells the story of Richard Bergström’s mission as Sweden’s...

ZEISS Quality Innovation Summit video

An event full of experiences, talks, innovations, speeches, and state-of-the-art technology.